Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0XWTYJ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DXC-005
|
|||||
| Synonyms |
DXC 005; DXC005; Recombinant humanized anti-Muc1 antibody conjugated to Tub201
Click to Show/Hide
|
|||||
| Organization |
Hangzhou DAC Biotech Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 2 Indication(s)
Colorectal cancer [ICD11:2B91]
Phase 1
Pancreatic cancer [ICD11:2C10]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Mucin-1 (MUC1)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.